1. Home
  2. GHLD vs RCUS Comparison

GHLD vs RCUS Comparison

Compare GHLD & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • RCUS
  • Stock Information
  • Founded
  • GHLD 1960
  • RCUS 2015
  • Country
  • GHLD United States
  • RCUS United States
  • Employees
  • GHLD N/A
  • RCUS N/A
  • Industry
  • GHLD Finance: Consumer Services
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GHLD Finance
  • RCUS Health Care
  • Exchange
  • GHLD Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • GHLD 813.7M
  • RCUS 906.4M
  • IPO Year
  • GHLD 2020
  • RCUS 2018
  • Fundamental
  • Price
  • GHLD $19.76
  • RCUS $8.63
  • Analyst Decision
  • GHLD Hold
  • RCUS Buy
  • Analyst Count
  • GHLD 6
  • RCUS 10
  • Target Price
  • GHLD $16.30
  • RCUS $23.75
  • AVG Volume (30 Days)
  • GHLD 67.2K
  • RCUS 1.1M
  • Earning Date
  • GHLD 08-07-2025
  • RCUS 08-07-2025
  • Dividend Yield
  • GHLD 2.53%
  • RCUS N/A
  • EPS Growth
  • GHLD 63.18
  • RCUS N/A
  • EPS
  • GHLD 0.71
  • RCUS N/A
  • Revenue
  • GHLD $1,131,796,000.00
  • RCUS $141,000,000.00
  • Revenue This Year
  • GHLD $5.64
  • RCUS N/A
  • Revenue Next Year
  • GHLD $26.37
  • RCUS $28.73
  • P/E Ratio
  • GHLD $27.80
  • RCUS N/A
  • Revenue Growth
  • GHLD 32.57
  • RCUS N/A
  • 52 Week Low
  • GHLD $11.21
  • RCUS $6.50
  • 52 Week High
  • GHLD $20.15
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 82.47
  • RCUS 44.17
  • Support Level
  • GHLD $14.69
  • RCUS $8.75
  • Resistance Level
  • GHLD $20.15
  • RCUS $9.35
  • Average True Range (ATR)
  • GHLD 0.63
  • RCUS 0.62
  • MACD
  • GHLD 0.54
  • RCUS -0.15
  • Stochastic Oscillator
  • GHLD 94.54
  • RCUS 13.14

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: